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Abstract
We examined the associations between extracerebral markers of cholesterol homeostasis and cognitive decline over 6 years of follow-up,
and studied the modifying effect of apolipoprotein E (ApoE) e4. Data were collected in the Longitudinal Aging Study Amsterdam (n 967,
ith longitudinal data on cognition, ages  65 years) and analyzed using linear mixed models. General cognition (Mini-Mental State
xamination; MMSE), memory (Auditory Verbal Learning Test), and information processing speed (Coding task) were measured. The
esults show that ApoE e4 was a significant effect modifier. Significant associations were found only in ApoE e4 noncarriers (n  718).
We found a nonlinear negative association between the ratio of lanosterol to cholesterol ( 189.96 ng/mg), a marker for cholesterol
synthesis, and general cognition. Lower cholesterol absorption, i.e., lower ratios of campesterol and sitosterol to cholesterol, as well as a
higher rate of cholesterol synthesis relative to absorption were associated with lower information processing speed. In ApoE e4 carriers, the
negative association between the ratio of campesterol to cholesterol and memory reached borderline significance. Future research should
focus on the interaction between (disturbed) cholesterol homeostasis and ApoE e4 status with respect to dementia.
© 2012 Elsevier Inc.
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Disturbed cerebral and extracerebral cholesterol homeo-
stasis has been suggested to play a role in dementia and
cognitive decline. Cholesterol homeostasis is the balance
between cholesterol absorption, synthesis, metabolism, and
excretion (Grundy, 1991). Lathosterol is a major precursor
in cholesterol biosynthesis. The ratio of lathosterol to cho-
lesterol is considered a reflection of cholesterol synthesis
(Miettinen et al., 1990). Lanosterol is the first common
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Open access under the Elsevier OA license.intermediate of 2 different pathways, which use either des-
mosterol or lathosterol as the predominant precursors for de
novo synthesis of brain cholesterol (Lütjohann et al., 2002).
The serum plant sterol sitosterol concentration is generally
considered as a measure of cholesterol absorption (Mietti-
nen et al., 1990). It has been shown that plant sterols such
as sitosterol or campesterol are effective as cholesterol low-
ering agents (Law, 2000; Plat and Mensink, 2001). Thus far
several studies have examined the association between cho-
lesterol homeostasis and cognitive decline. However, they
show inconsistent results and causality and mechanisms
underlying these associations remain to be further clarified
(Anstey et al., 2008; Helzner et al., 2009; Heverin et al.,
2004; Kölsch et al., 2004; Solomon et al., 2007, 2009).Apolipoprotein E (ApoE) is the major lipid transport
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metabolism (Poirier, 1996). The ApoE system is important
for the distribution of cholesterol in the brain and is partially
involved in its transfer from brain tissue to the cerebrospinal
fluid and from there to the circulation (Pitas et al., 1987).
Furthermore, carriers of the ApoE e4 allele are at increased
risk of cognitive decline and developing Alzheimer’s dis-
ease (AD) (Dik et al., 2000). In a previous study we showed
that ApoE e4 was a significant modifier of the longitudinal
associations between total serum cholesterol, the ratio of
27-hydroxycholesterol to cholesterol, and cognitive func-
tioning in late life. Lower cholesterol levels and a higher
ratio of 27-hydroxycholesterol to cholesterol were predic-
tive of worse cognitive functioning in older persons carry-
ing the ApoE e4 allele, but not in e4 noncarriers (Van den
Kommer et al., 2009).
To our knowledge no study has focused on the modify-
ing role of ApoE e4 on the associations between markers for
cholesterol synthesis and absorption and cognitive decline
or dementia. The goal of the present study is to investigate
the longitudinal associations between lanosterol, lathosterol,
sitosterol, and campesterol, and cognitive functioning and
the modifying role of ApoE e4 on these associations.
2. Methods
2.1. Study sample
Data were collected within the Longitudinal Aging Study
Amsterdam (LASA), an ongoing population-based study
(Deeg et al., 2002). A random sample of older men and
women, stratified by age and sex according to the expected
5-year mortality, was drawn from the population registries
of 11 municipalities in 3 areas of the Netherlands. Data
collection started in 1992/1993, and includes follow-up
measurements every 3 years. In total, 3107 subjects between
the ages of 55 and 85 were enrolled during the first data
collection of LASA, of whom 2545 (81.9%) were inter-
viewed during the second data collection (1995/1996). Loss
to follow-up was mainly due to mortality (74%). During the
second data collection, blood samples were obtained in
persons aged 65 years and older. Of the 1720 eligible
respondents, 1352 persons agreed to take part in the blood
drawing procedure. For the present study, persons were
included of whom a blood sample was obtained and sterol
levels could be determined (n  1248). Subjects of whom
blood samples could not be obtained were significantly
older and had lower scores on cognition (all p  0.0001)
compared with subjects of whom blood samples were avail-
able. Persons using lipid-lowering drugs at the time of blood
sampling were excluded (n  67), resulting in 1181 sub-
jects. Of these 1181 respondents, 1003 (84.9%) also partic-
ipated in the 3-year follow-up interviews (1998/1999). Of
the 178 subjects lost to follow-up, 149 had died (12.6%), 12
refused (1.0%), 11 were too frail (0.9%), and 6 could not be
contacted (0.6%). Of the 1003 respondents participating inthe 3-year follow-up, 826 (82.4%) also participated in the
interviews during the 6-year follow-up (2001/2002). Of
those lost to follow-up, 154 had died (15.9%), 8 refused
(0.8%), 9 were too frail (0.9%) and 1 could not be contacted
(0.1%). Subjects who were lost to follow-up were signifi-
cantly older, had lower scores on cognition, and were more
likely to be men and to have cardiovascular disease (all p 
0.0001). Furthermore, they had significantly lower levels of
cholesterol (p  0.003), lower absolute levels of campes-
terol (p  0.027), sitosterol (p  0.001), and lathosterol
(p  0.004), and lower ratios of lathosterol to cholesterol
(p  0.011) at baseline compared with persons who re-
mained in the study. In the present study, analyses were
based on persons of whom data on cognitive functioning
were available on at least 2 occasions, which resulted in a
final sample of n  967.
2.2. Cognitive functioning
General cognitive performance was measured with the
Mini-Mental State Examination (MMSE) (Folstein et al.,
1975). Scores range from 0 to 30, a higher score indicating
better performance.
Memory was measured with an abbreviated version of
the Auditory Verbal Learning Test (AVLT) (Rey, 1964).
We used 3 instead of 5 learning trials to reduce the burden
for the respondent. In each trial, the interviewer read aloud
a list of 15 words, after which the respondents summed up
as many words as they could remember. Immediate recall
(highest score out of 3 trials; range, 0–15) was derived from
this test. At follow-up, a parallel version of the Auditory
Verbal Learning Test was used. The parallel versions,
which are used in treatment research (Moller et al., 1998),
were validated and tested on parallelism (Jolles et al., 1995).
Information processing speed was measured by an
adapted version of a timed letter substitution task, the Al-
phabet Coding Task-15 (Piccinin and Rabbitt, 1999). The
respondent had to combine as many characters as possible
according to a given example. The task consisted of 3
identical 1-minute trials. The score on each trial consisted of
the number of correctly completed characters. The mean
score of the 3 trials was used in the analyses (range,
1–42.7).
2.3. Sterol levels
Morning blood samples were obtained. Participants were
allowed to take tea and toast, but no dairy products. Serum
samples were obtained and frozen at -80 °C until analysis.
Cholesterol was determined by highly sensitive gas chro-
matography-flame ionization detection. Plasma concentra-
tions of sitosterol, campesterol, lathosterol, lanosterol, and
27-hydroxycholesterol were assessed using an ultrasensitive
and highly specific gas chromatography-mass spectrometry
selective ion-monitoring method (Sudhop et al., 2002).
Identity of all sterols was confirmed by comparison with the
full scan mass spectra of the authentic compounds. The
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sterols were below 3% of the respective mean values (pre-
cision). Interassay accuracy was lower than 3% of the re-
spective nominal values. The limit of quantification was 
0.001 mg/dL for each sterol. The sterol to cholesterol ratios
were defined as the absolute amount of lathosterol, lanos-
terol, sitosterol, and campesterol divided by the absolute
amount of cholesterol. The ratios of lathosterol to the plant
sterols were computed by dividing the absolute amount of
lathosterol by the absolute amount of the campesterol and
sitosterol respectively.
2.4. Apolipoprotein E phenotype
Serum samples were obtained and frozen at80 °C until
determination of ApoE phenotype. The ApoE phenotype
was determined by isoelectric focusing of delipidated serum
samples, followed by immunoblotting (Havekes et al.,
1987). The distribution of ApoE phenotypes was in Hardy-
Weinberg equilibrium (ApoE e2/2: 0.8%; e2/3: 11.8%;
e3/3: 60.9%; e2/4: 2.7%; e3/4: 20.6%; e4/4: 3.0%; missing:
0.3%). ApoE status was classified as e4 carriers for subjects
with the ApoE e4 isoform (phenotypes e2/4, e3/4, e4/4) and
as e4 noncarriers for subjects without the ApoE e4 isoform
(phenotypes e2/2, e2/3, e3/3).
2.5. Potential confounders
Age, sex, education, hypertension, diabetes mellitus, de-
pressive symptoms, body mass index (BMI), alcohol intake,
smoking status, and use of lipid-lowering drugs at follow-up
were considered as potential confounders.
Education was assessed by asking the respondent for the
highest educational level completed, which was converted
into the total number of years of education (range, 5–18
years). Hypertension was defined by sitting blood pressure,
 160/100 mm/Hg, use of antihypertensive medication or
oth. Diabetes mellitus was assessed by self-report (nearly
erfect agreement with general practitioners (GP) informa-
ion, kappa 0.85) (Kriegsman et al., 1996) and medication
use. Depressive symptoms were assessed with the Center
for Epidemiologic Studies Depression Scale (Beekman et
al., 1997; Radloff, 1977), a 20-item self-report scale (range,
0–60) designed to measure depressive symptoms in the
general population. BMI was calculated as weight (kg)/
height (m2). Alcohol consumption was assessed by asking
the number of alcoholic units per week over the past year,
and the number of days in the week in which alcohol was
consumed, and was classified as no, middle, and high con-
sumption according to the Netherlands Economic Institute
(NEI) index (Reinhard and Rood-Bakker, 1998). Smoking
status was classified as never, former, and current smokers.
Use of lipid-lowering drugs was determined by checking
medication use.
Cardiovascular disease (cardiac disease, peripheral arte-
rial disease, cerebrovascular accident) was evaluated as a
potential mediator. The presence of cardiovascular disease tat baseline and 3-year follow-up was assessed by a combi-
nation of self-report data, medication use, and GP records in
an algorithm previously described (Bremmer et al., 2006).
At 6-year follow-up self-report data and medication records
were used.
2.6. Data analysis
Characteristics of the study sample by ApoE e4 status
were compared using Mann-Whitney U tests for indepen-
dent samples. The MMSE score was transformed (ln (31-
MMSE score)) to obtain a near-normal distribution. Corre-
lations between absolute values of all markers, ratios of all
markers to cholesterol, and total cholesterol, absolute values
of 27-hydroxycholesterol and its ratio to cholesterol were
studied by means of Pearson correlation coefficients.
To study the longitudinal associations between the ratio
of lathosterol, lanosterol, sitosterol, and campesterol to cho-
lesterol and cognitive functioning, and the modifying effect
of ApoE e4 on these associations, data were analyzed using
linear mixed models in SPSS version 15.0. All markers
were studied as continuous variables. Quadratic terms and
interactions were tested at the 0.10 significance level. Main
effects were tested at the 0.05 significance level.
First, the trajectories of cognitive functioning as indi-
cated by scores on the MMSE, immediate recall, and infor-
mation processing speed were modeled as a function of
time. Time was defined as the number of years (i.e., 0, 3,
and 6 years) between sterol determination and follow-up
cycle. Second, in separate analyses the main predictors were
added to each model and their quadratic term was tested for
significance to study the presence of a nonlinear association.
If significant (p  0.10), the quadratic term was retained in
he model. Third, the interaction between the main predictor
nd time was tested to study whether the main predictor was
ssociated with rate of cognitive decline. If significant (p 
.10) the interaction with time was retained in the model.
ereafter, all potential confounders were added 1 by 1 to the
odel. Variables that showed a significant confounding
ffect on the associations studied, i.e., 10% change in the
nstandardized regression coefficient (B) of the main pre-
ictor, were retained in the model.
Effect modification by ApoE e4 status (yes, no) was
ested in the fully adjusted models by adding the product
erms (main predictor*ApoE e4 status) in separate analyses.
f significant (p  0.10), the additive effect of the main
redictor centered at different percentiles (10th, 25th, 50th,
5th, and 90th) and the presence of the ApoE e4 allele on
ognitive functioning was tested. Predictors were centered
o test for significance of the main effects at these different
evels and thus improve interpretability. If a significant
odifying effect was not found, ApoE e4 was added to the
odel to test for potential confounding.
In addition, analyses were repeated after exclusion of
ersons with cardiovascular disease at baseline or follow-up
o study the mediating effect of cardiovascular disease on
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tion.
Finally, in additional analyses (see Supplementary data)
we studied the associations between the absolute values of
all markers and cognitive functioning. Also, the interaction
between hyperlipidemic status, defined as total cholesterol
levels250.90 mL/dL (6.5 mmol/L) (yes, no), and absolute
levels and ratios to cholesterol of all markers were studied
in the fully adjusted models.
3. Results
Table 1 shows the baseline characteristics for the total
tudy sample, ApoE e4 carriers, and e4 noncarriers. The
mounts of cholesterol as well as the absolute levels of the
lant sterols proved significantly higher in ApoE e4 carriers
ompared with e4 noncarriers.
Correlations between absolute levels and the ratios to
Table 1
Baseline characteristics for the total study sample with longitudinal data o
noncarriers
Characteristic Unit T
Age, years, mean (SD)
Female, % (n)
Education, years, mean (SD)a
Depressive symptoms, mean (SD)a
Hypertension, % (n)a
Diabetes mellitus, % (n)
Cardiovascular disease, % (n)
Body mass index, mean (SD)a
Smoking, % (n)
No
Former
Current
Alcohol consumption, % (n)a
No
Middle
High
MMSE score, mean (SD) (n  967)
Immediate recall, mean (SD) (n  912)
Information processing speed, mean (SD) (n  898)
Sterol concentrations in serum
Cholesterol, mean (SD) mg/dL 2
Cholesterol precursors
Lathosterol, mean (SD)
Absolute mg/dL
Ratio to cholesterol g/mg
Lanosterol, mean (SD)
Absolute g/dL
Ratio to cholesterol ng/mg 1
Plant sterols
Campesterol, mean (SD)
Absolute mg/dL
Ratio to cholesterol g/mg
Sitosterol, mean (SD)
Absolute mg/dL
Ratio to cholesterol g/mg
values indicate whether value distributions significantly vary between t
ey: ApoE, apolipoprotein E; MMSE, Mini-Mental State Examination.
a Missing values.holesterol of all markers, and total cholesterol, absolutelevels, and the ratio of 27-hydroxycholesterol to cholesterol
are shown in Table 2.
Table 3 shows the results of the longitudinal mixed
models analyses in which the associations between the ste-
rol ratios to cholesterol, and the ratios of lathosterol to
campesterol and sitosterol, and cognitive functioning were
studied in the total sample, as well as effect modification of
these associations by ApoE e4 in the fully-adjusted models.
3.1. Main effects
We studied all markers as continuous variables in the
total study sample. To test for nonlinearity of the associa-
tions studied, the quadratic term of each main predictor was
added to the time-adjusted models in separate analyses for
each outcome measure and predictor. The results show that
only the quadratic term of the ratio of lanosterol to choles-
terol reached significance in both the time- and fully-ad-
itive functioning and separately for apoe e4 carriers and apoe e4
mple (n  967) ApoE e4 (n  247) ApoE e4 (n  718)
6.39) 74.76 (6.45) 75.08 (6.38)
515) 50.60 (125) 54.20 (389)
6.39) 9.14 (3.22) 8.98 (3.28)
7.51) 7.21 (7.20) 8.01 (7.61)
539) 59.20 (145) 55.20 (394)
62) 4.50 (11) 7.10 (51)
275) 29.60 (73) 28.30 (203)
4.09) 26.93 (3.88) 26.82 (4.15)
360) 36.00 (89) 37.60 (270)
438) 47.80 (118) 44.60 (320)
169) 16.20 (40) 17.80 (128)
238) 21.50 (53) 24.40 (175)
643) 68.80 (170) 65.70 (471)
95) 9.70 (24) 9.90 (71)
2.57) 27.01 (2.61) 27.20 (2.50)
2.49) 8.63 (2.47) 8.34 (2.47)
6.86) 23.95 (6.64) 24.03 (6.64)
45.55) 242.55 (44.10) 233.37 (45.82)**
0.12) 0.28 (0.12) 0.28 (0.12)
0.53) 1.18 (0.49) 1.24 (0.54)
9.24) 33.03 (8.31) 32.77 (9.55)
46.80) 138.92 (38.70) 144.30 (49.26)
0.19) 0.38 (0.21) 0.35 (0.19)*
0.77) 1.57 (0.84) 1.48 (0.75)
0.17) 0.35 (0.18) 0.32 (0.17)*
0.68) 1.45 (0.72) 1.39 (0.66)
E e4 carriers and e4 noncarriers *p  0.05, **p  0.01.n cogn
otal sa
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processing speed. This indicates that the association be-
tween the ratio of lanosterol to cholesterol and the trajectory
of information processing speed and general cognitive per-
formance was nonlinear (i.e., a threshold was found above
which the association is no longer significant), thus the
quadratic term of the ratio of lanosterol to cholesterol was
retained only in these models (see Table 3). By subse-
quently centering the ratio of lanosterol to cholesterol at
different percentiles we were able to identify the inflexion
point.
In the time-adjusted models the results show that a
higher ratio of lanosterol to cholesterol was significantly
associated with a higher ln transformed MMSE score (i.e.,
worse general cognitive performance) and lower informa-
tion processing speed. Table 3 shows only the strength and
significance level of the linear and quadratic term of the
ratio of lanosterol to cholesterol centered at the 10th per-
centile. No significant associations were found between the
ratio of lathosterol to cholesterol and cognitive functioning.
Furthermore, a significant association was found between a
higher ratio of the plant sterols to cholesterol and a lower ln
transformed MMSE score (i.e., better general cognitive per-
formance) and higher information processing speed. In ad-
dition, a higher ratio of sitosterol to cholesterol was signif-
icantly associated with better immediate recall. Finally, the
time-adjusted models showed a significant positive associ-
ation between the ratios of lathosterol to the plant sterols
and the ln transformed MMSE score and a significant
negative association between these ratios and immediate
recall and information processing speed. This indicates that
a relatively higher rate of cholesterol synthesis compared
with cholesterol absorption was significantly associated
with lower general cognitive performance, memory perfor-
mance, and information processing speed. No significant
interactions with time were found, indicating that none of
Table 2
Correlations between markers, total cholesterol and 27-hydroxycholestero
Total cholesterol
holesterol precursors
Absolute levels of lanosterol 0.270**
Ratio of lanosterol to cholesterol 0.399**
Absolute levels of lathosterol 0.306*
Ratio of lathosterol tot cholesterol 0.167**
Plant sterols
Absolute campesterol levels 0.348**
Ratio of campesterol to cholesterol 0.016
Absolute sitosterol levels 0.358**
Ratio of sitosterol to cholesterol 0.000
Cholesterol synthesis relative to absorption
Ratio of lathosterol to campesterol 0.127**
Ratio of lathosterol to sitosterol 0.119**
* p  0.05.
** p  0.01.the markers of cholesterol homeostasis were significantly (associated with rate of cognitive decline. Furthermore, the
absence of significant interactions between the markers of
cholesterol homeostasis and time indicates that the strength
of the associations found remained constant over time.
In the fully-adjusted models, only the (nonlinear) asso-
ciation between the ratio of lanosterol to cholesterol and the
ln transformed MMSE score remained significant. The re-
sults indicate that a higher ratio of lanosterol to cholesterol
was significantly associated with lower general cognitive
performance over 6 years of follow-up independent of rel-
evant confounders. Further analyses show that this associ-
ation was significant up to a ratio of lanosterol to cholesterol
of 205.00 (ng/mg). In Fig. 1, the trajectory of performance
on the MMSE score is shown according to the ratio of
lanosterol to cholesterol. The negative association between
the ratio of lanosterol of cholesterol (centered at the 10th
percentile) and information processing speed reached bor-
derline significance (p  0.066). All other associations lost
tatistical significance after adjustment for relevant con-
ounders.
.2. Effect modification by ApoE e4
The results as presented in Table 3 show a significant
nteraction between the quadratic term of the ratio of lanos-
erol to cholesterol and ApoE e4 status in the model pre-
icting the ln transformed MMSE score. The positive non-
inear association between the ratio of lanosterol to
holesterol and the ln transformed MMSE score was signif-
cant only in ApoE e4 noncarriers (Fig. 2). Analyses showed
hat this association was significant up to a ratio of 189.95
ng/mg).
The negative nonlinear association between the ratio of
anosterol to cholesterol and information processing speed
eached significance in ApoE e4 noncarriers; although no
ignificant effect modification by ApoE e4 status was found
terol levels
27-hydroxycholesterol Ratio of 27-hydroxycholesterol
to cholesterol
0.382** 0.253**
0.067* 0.462**
0.266** 0.086**
0.064* 0.255**
0.298** 0.053
0.141** 0.135**
0.318** 0.076*
0.160** 0.180**
0.076* 0.021
0.085** 0.005l cholessee Table 3). However, further analyses showed that only
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Associations between sterols and cognitive performance over 6 years of follow-up separately for total study sample, e4 carriers, and e4 noncarriers
Ln transformed MMSE (direction of associations is reversed because of ln [natural log] transformation)
Total sample (n  967) ApoE e4 (n  718) ApoE e4 (n  247)
B time
adjusted
p
value
B fully
adjusted
p
value
B fully
adjusted
p
value
B fully
adjusted
p
value
p interaction
term
Precursors
r_lath 0.060 0.072 0.016a 0.598 0.019a 0.564 0.0032a 0.958 0.814
r_lano at p10 0.0018 0.002 0.0014b 0.008 0.0014b 0.018 0.00027b 0.837 0.434
r_lano*r_lano 0.44*10-5 0.020 0.30*10-5 0.072 0.34*10-5 0.048 0.96*10-5 0.141 0.054
lant sterols
r_camp 0.050 0.028 0.0058c 0.785 0.0033c 0.895 0.033c 0.390 0.422
r_sito 0.072 0.006 0.0081d 0.773 0.020d 0.480 0.021d 0.625 0.421
holesterol synthesis relative to absorption
lath_camp 0.072 0.000 0.013e 0.438 0.018e 0.336 0.0055e 0.874 0.549
lath_sito 0.070 0.000 0.020f 0.232 0.027f 0.134 0.0085f 0.809 0.362
Immediate recall
Total sample (n  918) ApoE e4 (n  683) ApoE e4 (n  234)
B time
adjusted
p
value
B fully
adjusted
p
value
B fully
adjusted
p
value
B fully
adjusted
p
value
p interaction
term
recursors
r_lath 0.091 0.533 0.13g 0.313 0.12g 0.416 0.22g 0.407 0.725
r_lano 0.0025 0.140 0.00011h 0.937 0.00018h 0.909 .0015h 0.647 0.638
Plant sterols
r_camp 0.20 0.051 0.16i 0.853 0.11i 0.305 0.29i 0.052 0.029
r_sito 0.26 0.021 0.036j 0.723 0.11j 0.354 0.17j 0.364 0.199
Cholesterol synthesis relative to absorption
lath_camp 0.19 0.019 0.034j 0.640 0.00040j 0.996 0.17j 0.244 0.304
lath_sito 0.17 0.042 0.028k 0.707 0.0045k 0.957 0.16k 0.285 0.331
Information processing speed
Total sample (n  898) ApoE e4 (n  667) ApoE e4 (n  230)
B time
adjusted
p
value
B fully
adjusted
p
value
B fully
adjusted
p
value
B fully
adjusted
p
value
p interaction
term
Precursors
r_lath 0.60 0.157 0.096l 0.783 0.25l 0.528 0.43l 0.545 0.398
r_lano at p10 0.016 0.039 0.012b 0.066 0.014b 0.044 0.0070b 0.650 0.210
r_lano*r_lano 0.63*104 0.008 0.47*104 0.016 0.54*104 0.007 0.53*104 0.478 0.167
lant sterols
r_camp 1.09 0.000 0.25b 0.313 0.71b 0.017 0.67b 0.111 0.007
r_sito 1.25 0.000 0.34b 0.214 0.79b 0.016 0.65b 0.185 0.014
holesterol synthesis relative to absorption
lath_camp 1.06 0.000 0.32m 0.107 0.57m 0.011 0.54m 0.189 0.017
lath_sito 1.01 0.000 0.31m 0.124 0.54m 0.018 0.46m 0.267 0.034
ey: ApoE, apolipoprotein E; B, unstandardized regression coefficient; BMI, body mass index; lath_camp, ratio of lathosterol to campesterol (mg/mg);
ath_sito, ratio of lathosterol to sitosterol (mg/mg); MMSE, Mini-Mental State Examination; p10, 10th percentile; r_camp, ratio of campesterol to cholesterol
g/mg); r_lano, ratio of lanosterol to cholesterol (ng/mg); r_lath, ratio of lathosterol to cholesterol (g/mg); r_sito, ratio of sitosterol to cholesterol (g/mg).
a Adjusted for time, age, sex, education, diabetes mellitus, BMI, alcohol, and ApoE e4.
b Adjusted for time, age, sex, and education.
c Adjusted for time, age, education, diabetes mellitus, BMI, and depressive symptoms.
d Adjusted for time, age, education, diabetes mellitus, BMI, depressive symptoms, alcohol, smoking, and ApoE e4.
e Adjusted for time, age, education, diabetes mellitus, BMI, alcohol, and ApoE e4.
f Adjusted for time, age, education, and diabetes mellitus.
g Adjusted for time, age, sex, education, diabetes mellitus, BMI, and alcohol.
h Adjusted for time, age, sex, education, diabetes mellitus, hypertension, BMI, alcohol, smoking, and ApoE e4.
i Adjusted for time, age, sex, education, and diabetes mellitus.
j Adjusted for time, age, sex, education, diabetes mellitus, BMI, depressive symptoms, and alcohol.
k Adjusted for time, age, sex, education, diabetes mellitus, BMI, depressive symptoms, alcohol, and smoking.
l Adjusted for time, age, sex, education, diabetes mellitus, BMI, depressive symptoms, and ApoE e4.m Adjusted for time, age, and education.
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622.e23T. van den Kommer et al. / Neurobiology of Aging 33 (2012) 622.e17–622.e28in persons with the lowest ratios of lanosterol to cholesterol
(111.14 ng/mg) the association with information process-
ing speed was significant.
Furthermore, in the model predicting immediate recall, a
significant interaction between the ratio of campesterol to
cholesterol and ApoE e4 was found. In ApoE e4 carriers,
the main effect of the ratio of campesterol to cholesterol on
memory performance approached significance (p  0.052).
lso, a significant interaction between ApoE e4 and the
atio of campesterol and sitosterol to cholesterol, and la-
hosterol to campesterol and sitosterol in the models pre-
icting information processing speed was found. Only in e4
oncarriers, a significant association was found between a
igher ratio of the plant sterols to cholesterol and higher
nformation processing speed over 6 years of follow-up,
ndependent of relevant confounders. Fig. 3 shows the tra-
ectory of information processing speed according to the
atio of the plant sterols to cholesterol in ApoE e4 noncar-
iers.
Furthermore, a significant association between a higher
atio of lathosterol to the plant sterols and lower information
rocessing speed was found, only in ApoE e4 noncarriers.
his indicates that a relatively higher rate of cholesterol
ynthesis relative to absorption was significantly associated
ith lower information processing speed. This result is
hown in Fig. 4.
.3. Sensitivity analyses
In order to study whether the presence of cardiovascular
isease at baseline or follow-up was a significant mediator
f the studied associations, all analyses were repeated in the
ample excluding persons with cardiovascular disease (n 
01). Overall, the results show no substantial change in the
nstandardized B of the main predictors with respect to the
Figure 1. Six-year cognitive decline according to the ratio of lanosterol to
cholesterol in total sample, adjusted for time, age, sex, and education.
MMSE, Mini Mental State Examination.ssociation with cognitive functioning (data not shown).his indicates that the presence of cardiovascular disease
ould not explain the associations found.
. Discussion
This prospective population-based study focused on the
ssociations between extracerebral markers of cholesterol
ynthesis, markers of cholesterol absorption, and cognitive
unctioning over 6 years of follow-up in older persons. We
howed a significant independent nonlinear association be-
ween a higher rate of cholesterol synthesis as reflected by
higher ratio of lanosterol to cholesterol, and worse general
ognitive performance. It was shown that this association
as significant up to a threshold value of the ratio of
anosterol to cholesterol of 205.00 ng/mg. Furthermore, this
ssociation was significant in ApoE e4 noncarriers (up to a
hreshold value of the ratio of lanosterol to cholesterol of
89.95 ng/mg), but not in ApoE e4 carriers. It was shown
hat the mean level of cognitive performance after 3 years of
ollow-up in ApoE e4 noncarriers with a ratio of lanosterol
o cholesterol in the 10th percentile was approximately the
ame as the baseline level in those with a ratio in the 90th
ercentile. In addition, it was shown that a higher rate of
holesterol absorption as reflected by a higher ratio of
ampesterol and sitosterol to cholesterol was independently
ssociated with higher information processing speed, only
n ApoE e4 noncarriers. On average, level of information
rocessing speed after 3 years of follow-up in ApoE e4
oncarriers with a rate of cholesterol absorption in the 90th
ercentile was similar to baseline information processing
peed in those in the 10th percentile. In ApoE e4 carriers,
he association between a higher rate of cholesterol absorp-
ion as reflected by the ratio of campesterol to cholesterol,
nd worse memory performance approached statistical sig-
ificance. Finally, in ApoE e4 noncarriers a higher rate of
holesterol synthesis relative to cholesterol absorption was
Figure 2. Six-year cognitive decline according to the ratio of lanosterol to
cholesterol in ApoE e4 noncarriers, adjusted for time, age, sex, and edu-
cation. MMSE, Mini Mental State Examination.
622.e24 T. van den Kommer et al. / Neurobiology of Aging 33 (2012) 622.e17–622.e28shown to predict lower information processing speed over 6
years of follow-up. The mean level of information process-
ing speed after 3 years of follow-up in ApoE e4 noncarriers
with a rate of cholesterol synthesis relative to absorption in
the 10th percentile was comparable to the mean level of
baseline information processing speed in persons with a rate
in the 90th percentile. In addition, the present study showed
that the strength of the associations between these markers
and level of cognitive functioning remained unchanged over
time. No significant associations between the studied mark-
ers of cholesterol metabolism and a faster rate of cognitive
decline were found.
Additional analyses (see Supplementary data) showed
that the direction of the associations found when studying
the absolute levels of the sterols was consistent with the
direction of the associations found when studying the effect
Figure 3. Six-year cognitive decline according to the ratio of plant sterol
tion.
Figure 4. Six-year cognitive decline according to the rate of cholesterol sy
education.of the ratios of the sterols to cholesterol on cognitive func-
tioning. Also, in some instances a modifying effect of hy-
perlipidemia was found, indicating that some of the signif-
icant positive associations between the absolute levels of the
plant sterols and cognitive functioning were significant only
in nonhyperlipidemic persons.
4.1. Cholesterol synthesis
The present findings on cholesterol synthesis are incon-
sistent with the results from a previous population-based
study (Teunissen et al., 2003). In contrast with our findings,
Teunissen et al. (2003) showed that a higher ratio of la-
thosterol to cholesterol at baseline was predictive of lower
cognitive functioning. Furthermore, while they found a sig-
nificant linear association between a higher ratio of lanos-
lesterol in ApoE e4 noncarriers, adjusted for time, age, sex, and educa-
relative to absorption in ApoE e4 noncarriers adjusted for time, age, ands to chonthesis
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mance and executive functioning, the current study showed
a nonlinear association with lower general cognitive perfor-
mance, but not with memory performance. These inconsis-
tent results may be due to differences in study sample. The
present study sample was older (mean age of 75.0 vs. 57.4
years) and had higher cholesterol, lanosterol, and lathosterol
levels at baseline. Also, in the present study the nonlinear
association between a higher ratio of lanosterol to choles-
terol and lower general cognitive performance was signifi-
cant in ApoE e4 noncarriers but not in e4 carriers. Teunissen
et al. (2003) did not study the modifying role of ApoE e4.
In a recent cross sectional study it was shown that in
persons with subjective memory impairment (mean age
57.5 years), but not in mild cognitive impairment (MCI) and
AD patients, a higher ratio of lanosterol and lathosterol to
cholesterol was significantly associated with lower brain
volumes (Solomon et al., 2009). In a postmortem study it
was concluded that de novo synthesis of cholesterol but not
the cholesterol amount itself declines with aging in the
hippocampus (Thelen et al., 2006). However, another recent
postmortem study (mean age  85 years, SD  6) showed
his age-related decrease of cholesterol synthesis only in the
rains of AD patients, and the opposite effect in persons
ith no cognitive impairment (Hascalovici et al., 2009).
hus, current evidence suggests a complex interaction be-
ween age and (brain) sterol homeostasis (Hascalovici et al.,
009; Thelen et al., 2006).
.2. Cholesterol absorption
In line with the study by Teunissen et al. (2003), no
ignificant associations were found between the ratio of
ampesterol and sitosterol to cholesterol and cognitive func-
ioning in the total study sample. However, in the model
redicting information processing speed and immediate re-
all, we found a significant interaction between these mark-
rs and ApoE e4. In ApoE e4 noncarriers, a significant
ssociation between higher cholesterol absorption and faster
nformation processing speed was found, while in ApoE e4
arriers, a higher rate of cholesterol absorption was associ-
ted with worse memory performance. In a previous study
e found that especially in ApoE e4 carriers, lower choles-
erol was associated with faster decline in information pro-
essing speed. Levels of total cholesterol were however not
ignificantly associated with memory performance (Van den
ommer et al., 2009). Also, the ratio of campesterol to
holesterol, indicative of cholesterol absorption, was not
ignificantly correlated with total cholesterol. This in con-
rast to absolute campesterol levels, which showed a posi-
ive correlation with cholesterol. Taken together, the bor-
erline significant association between a higher rate of
holesterol absorption and worse memory performance in
poE e4 carriers does not seem to be related to hypercho-
esterolemia. It may be speculated that this indicates that a
igher rate of cholesterol absorption in ApoE e4 carriers is cssociated with increased risk of AD. In a study among
ealthy middle-aged men it was suggested that especially
hose with the ApoE e4 allele are at increased risk of the
utative adverse effects of plant sterols, for example, pre-
ature atherosclerosis (Nissinen et al., 2008). In the present
tudy, additional analyses showed that this potentially ad-
erse effect of plant sterols on cognition in ApoE e4 carriers
nly reached significance in the model predicting memory
erformance. Overall, the present findings may indicate
ifferent pathways in ApoE e4 carriers versus noncarriers.
he findings also suggest that the negative effect of carrying
he ApoE e4 allele on cognitive functioning prevails over
he potential (negative) effects of plant sterols.
A recent randomized double-blind placebo controlled
rial in statin treated hypercholesterolemic persons showed
hat long term consumption of plant sterols and plant stanol
sters did not have significant effects on cognitive function-
ng (Schiepers et al., 2009). In light of the current findings,
t may be suggested that ApoE phenotype should be taken
nto account when studying the effect of dietary interven-
ions on cognitive functioning.
.3. Cholesterol synthesis versus absorption
The current study did not show significant associations
etween the ratio of lathosterol and the plant sterols and
ognitive performance in the total study sample, which
ontrasts with the study by Teunissen et al. (2003). They
howed a significant association between a higher la-
hosterol to campesterol and sitosterol ratio and worse mem-
ry performance, after adjustment for age, sex, and educa-
ion. Again, this inconsistency may be due to differences in
haracteristics between samples, such as age, general health,
nd level of the markers studied. However, in the current
tudy we showed that a higher rate of cholesterol synthesis
elative to absorption was associated with lower information
rocessing speed in ApoE e4 noncarriers but not in e4
arriers. Again, this suggests that the negative effect of
arrying the ApoE e4 allele prevails over the effect of
holesterol synthesis and absorption on cognitive function-
ng.
In light of the present findings, future studies should
ocus on the potential differential effect of lipid-lowering
ompounds, affecting cholesterol synthesis and absorption
arkers, on cognition in ApoE e4 carriers and noncarriers.
See Supplementary data for a reflection on previous
ndings with respect to the associations between total cho-
esterol, 27-hydroxycholesterol, low-density lipoprotein
LDL) and high-density lipoprotein (HDL) cholesterol (Van
en Kommer et al., 2009, 2010).
.4. Strengths
The major strengths of the present study are that the
ssociations between several markers for cholesterol ho-
eostasis, ApoE phenotype, and both level and change inognitive functioning were studied. Cognitive performance
622.e26 T. van den Kommer et al. / Neurobiology of Aging 33 (2012) 622.e17–622.e28was examined on 3 different cognitive tests most sensitive
to age-related decline, on 3 occasions over 6 years of fol-
low-up. In addition, these associations were studied in a
large population-based sample including multiple relevant
confounding factors. To our knowledge, the interaction be-
tween markers for cholesterol synthesis and absorption and
ApoE e4 status on cognitive functioning and decline has not
been studied before.
It has been well established that cardiovascular risk is
related to dementia and cognitive decline. Weingärtner et al.
(2010) reviewed the accumulating evidence that altered
cholesterol homeostasis toward increased cholesterol ab-
sorption and reduced cholesterol synthesis is associated
with increased cardiovascular risk. Therefore, in the present
study sensitivity analyses were performed to exclude the
influence of cardiovascular disease on the associations stud-
ied. We showed that excluding persons with cardiovascular
disease at baseline or follow-up did not significantly change
the strength (or direction) of the associations found. How-
ever, the influence of subclinical cardiovascular disease on
the associations studied could not be fully excluded.
4.5. Limitations
A number of limitations need to be addressed. First,
sterol levels were only determined once, at baseline, not
during follow-ups. Thus, we were unable to study whether
a change in sterol levels was associated with cognitive
decline. In addition, similar to other population-based stud-
ies, the frailest persons with lower levels of cognitive func-
tioning refused blood sampling and were lost to follow-up.
Furthermore, there were some significant differences in
sterol levels between those lost to follow-up and those who
remained in the study. Persons lost to follow-up had signif-
icantly lower levels of cholesterol, lathosterol, plant sterols,
and a lower ratio of lathosterol to cholesterol at baseline
compared with those who remained in the study. This may
have lead to an underestimation of the strength of the
associations studied. Previous studies have shown that total
cholesterol tends to increase with age up to midlife, but
decreases over time after midlife (Abbott et al., 1997; Fer-
rara et al., 1997; Solomon et al., 2007). A reduced choles-
terol absorption rate has been shown in older men compared
with middle-aged men, which may be a major factor related
to decrease in serum cholesterol after midlife (Gylling et al.,
1994). It has been suggested that this decrease may be
explained by physiologic aging and reflects disease or a
gradual decline in overall health (Abbott et al., 1997; Fer-
rara et al., 1997).
Another potential limitation of the present study is the
lack of data on dietary intake. It has been suggested that
fatty fish and intake of n-3 fatty acids may play a protective
role with respect to age-related decline and dementia, al-
though studies have shown inconsistent results (Dullemeijer
et al., 2007; Van de Rest et al., 2009; Van Gelder et al.,2007). Thus, it would have been preferable to include di-
etary intake as a potential confounding factor.
Finally, the issue of reverse causality cannot be fully
dismissed. In LASA, a clinical dementia diagnosis based on
formal criteria is not available. However, at baseline we
identified only 3 persons showing persistent cognitive de-
cline, defined as clinically relevant decline over 3 years of
follow-up (2 SD below the mean) and continued decline
over the subsequent 3 years (Van den Kommer et al., 2008),
reducing the risk of reverse causality.
4.6. Conclusions
In sum, the present longitudinal population-based study
showed that a higher rate of cholesterol synthesis as re-
flected by a higher ratio of lanosterol to cholesterol was
predictive of lower general cognitive performance in the
total sample. This association was significant in ApoE e4
noncarriers, not in ApoE e4 carriers. In addition, higher
cholesterol absorption was significantly predictive of a rel-
atively faster information processing speed, only in ApoE
e4 noncarriers. Finally, only in ApoE e4 noncarriers, a
higher rate of cholesterol synthesis relative to cholesterol
absorption was significantly predictive of lower information
processing speed. Although absolute differences are some-
what small, overall the current findings showed a persistent
difference in level of cognitive functioning between ApoE
e4 noncarriers with sterol levels in the 10th percentile ver-
sus those with levels in the 90th percentile. Future research
should focus on the role of (disturbed) cholesterol homeo-
stasis and effect modification by ApoE e4 status with
respect to dementia.
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